Pulmicort Respules
Payments companies reported to CMS as associated with Pulmicort Respules. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Pulmicort Respules, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Pulmicort Respules
These are the largest totals companies reported as associated with Pulmicort Respules. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Raymond Townsend | Philadelphia, PA | Nephrology (Internal Medicine) | $97.72 |
| David Beuther | Denver, CO | Pulmonary Disease | $94.81 |
| Shyamsunder Subramanian | Tracy, CA | Pulmonary Disease | $94.81 |
| Jeffrey Barry | San Diego, CA | Critical Care Medicine (Internal Medicine) | $94.81 |
| Kovid Trivedi | Berkeley, CA | Pulmonary Disease | $94.81 |
| Vijaya Sarma | Chicago, IL | Internal Medicine | $31.85 |
| Eden Brandon | Chicago, IL | Internal Medicine | $22.96 |
| Benjamin Brewer | Forrest, IL | Family Medicine | $22.84 |
| Khoa Nguyen | Danville, IL | Nurse Practitioner | $21.82 |
| Teresita Torres | Watseka, IL | Family Medicine | $21.82 |
Prescribed Pulmicort Respules?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.